A phase I study of PF-05082566 (anti-4-1BB) + rituximab in patients with CD20+ NHL Meeting Abstract
| Authors: | Gopal, A. K.; Bartlett, N. L.; Levy, R.; Houot, R.; Smith, S. D.; Segal, N. H.; Thall, A. D.; Mugundu, G.; Huang, B.; Davis, C.; Kohrt, H. E. |
| Abstract Title: | A phase I study of PF-05082566 (anti-4-1BB) + rituximab in patients with CD20+ NHL |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036900638 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.3004 |
| Notes: | Meeting Abstract: 3004 -- Source: Wos |
